BRPI1014579A2 - método de transferência de polipeptídeo para células - Google Patents

método de transferência de polipeptídeo para células

Info

Publication number
BRPI1014579A2
BRPI1014579A2 BRPI1014579A BRPI1014579A BRPI1014579A2 BR PI1014579 A2 BRPI1014579 A2 BR PI1014579A2 BR PI1014579 A BRPI1014579 A BR PI1014579A BR PI1014579 A BRPI1014579 A BR PI1014579A BR PI1014579 A2 BRPI1014579 A2 BR PI1014579A2
Authority
BR
Brazil
Prior art keywords
cells
transfer method
polypeptide transfer
polypeptide
transfer
Prior art date
Application number
BRPI1014579A
Other languages
English (en)
Inventor
Katrin Edmaier
Ludwig Deml
Sascha Barabas
Original Assignee
Lophius Biosciences Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lophius Biosciences Gmbh filed Critical Lophius Biosciences Gmbh
Publication of BRPI1014579A2 publication Critical patent/BRPI1014579A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0634Cells from the blood or the immune system
    • C12N5/0636T lymphocytes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/02Peptides of undefined number of amino acids; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966Animal cells
    • G01N33/56972White blood cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
BRPI1014579A 2009-04-09 2010-04-09 método de transferência de polipeptídeo para células BRPI1014579A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09157777A EP2239569A1 (en) 2009-04-09 2009-04-09 Method for polypeptide transfer into cells
PCT/EP2010/054711 WO2010115984A1 (en) 2009-04-09 2010-04-09 Method for polypeptide transfer into cells

Publications (1)

Publication Number Publication Date
BRPI1014579A2 true BRPI1014579A2 (pt) 2016-04-26

Family

ID=40974538

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1014579A BRPI1014579A2 (pt) 2009-04-09 2010-04-09 método de transferência de polipeptídeo para células

Country Status (11)

Country Link
US (2) US9476878B2 (pt)
EP (2) EP2239569A1 (pt)
KR (1) KR101835647B1 (pt)
CN (1) CN102460161B (pt)
AU (1) AU2010233668B2 (pt)
BR (1) BRPI1014579A2 (pt)
CA (1) CA2758159C (pt)
EA (1) EA020583B1 (pt)
ES (1) ES2653561T3 (pt)
SG (2) SG175153A1 (pt)
WO (1) WO2010115984A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140213466A1 (en) * 2010-11-19 2014-07-31 Rutgers, The State University Of New Jersey High-throughput assessment method for contact hypersensitivity
WO2013166297A2 (en) * 2012-05-03 2013-11-07 Medimmune, Llc Method for analyzing sample components
CN103235135B (zh) * 2013-04-26 2015-02-04 史其新 一种用于表征外周调节性t细胞抑制活性的特征细胞群的检测方法及其应用
CN104031126B (zh) * 2014-06-27 2016-10-12 顾玉奎 一种自然杀伤t细胞活化剂多肽及其应用
CN104031125B (zh) * 2014-06-27 2016-10-05 顾玉奎 自然杀伤t细胞活化剂多肽及其应用
WO2016198470A2 (en) * 2015-06-08 2016-12-15 Lophius Biosciences Gmbh Composition for determination of cell-mediated immune responsiveness
CN106011060A (zh) * 2016-06-29 2016-10-12 北京中台恒基生物技术有限公司 一种体外激活和扩增nkt样细胞的方法
TW202334184A (zh) * 2021-11-10 2023-09-01 日商長瀨產業股份有限公司 SapB蛋白質之修飾體、SapB蛋白質及其修飾體之配製方法,以及溶解SapB蛋白質或其修飾體之水溶液

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1128005A (en) 1966-04-01 1968-09-25 Medimpex Gyogyszerkulkereskede Improvements in or relating to antigenic and allergenic preparations
FR2633518B1 (fr) 1988-06-30 1991-03-22 Merieux Inst Procede de stabilisation des vaccins et associations de vaccins a virus attenues conserves sous forme lyophilisee, et compositions obtenues
IT1237475B (it) 1989-10-06 1993-06-07 Allergeni modificati chimicamente e procedimento per la loro preparazione
AU693098B2 (en) * 1993-06-09 1998-06-25 Connaught Laboratories Limited Tandem synthetic HIV-1 peptides
EP0638593A1 (en) * 1993-08-02 1995-02-15 Shell Internationale Researchmaatschappij B.V. Catalyst compositions
US6977073B1 (en) * 1997-02-07 2005-12-20 Cem Cezayirli Method for stimulating an immune response
JP2002512808A (ja) 1998-04-28 2002-05-08 ワシントン ユニバーシティー 融合タンパク質の形質導入法
DE10212867B4 (de) 2002-03-22 2005-07-21 Hans Prof. Dr. Wolf Verwendung Harnstoff-adjuvierter Polypeptide zur Diagnose, Prophylaxe und Therapie
PL1961821T3 (pl) * 2007-02-22 2010-01-29 Polymun Scient Immunbiologische Forschung Gmbh Erytropoetynowe białko fuzyjne
CN104031393B (zh) * 2008-06-18 2017-08-01 生命连结有限公司 改进的交联组合物

Also Published As

Publication number Publication date
KR20120013373A (ko) 2012-02-14
US9850464B2 (en) 2017-12-26
US9476878B2 (en) 2016-10-25
SG10201401126QA (en) 2014-10-30
EA201171232A1 (ru) 2012-05-30
CN102460161A (zh) 2012-05-16
AU2010233668B2 (en) 2014-07-17
ES2653561T3 (es) 2018-02-07
CN102460161B (zh) 2017-08-29
EA020583B1 (ru) 2014-12-30
EP2417451A1 (en) 2012-02-15
SG175153A1 (en) 2011-11-28
CA2758159C (en) 2017-03-14
US20120093872A1 (en) 2012-04-19
KR101835647B1 (ko) 2018-03-08
CA2758159A1 (en) 2010-10-14
EP2417451B1 (en) 2017-09-27
US20170058260A1 (en) 2017-03-02
AU2010233668A1 (en) 2011-10-13
EP2239569A1 (en) 2010-10-13
WO2010115984A1 (en) 2010-10-14

Similar Documents

Publication Publication Date Title
BRPI1010035A2 (pt) Células deficientes em fucosilação
BRPI1009871A2 (pt) terapia para promover o crescimento celular
BRPI1009416A2 (pt) célula solar.
BRPI1010146A2 (pt) telha fotovoltaica para telhado
DK2448963T3 (da) T-celle receptorer
DE10836288T8 (de) Schwimmendes Stromkraftwerk
BRPI1012204A2 (pt) método de pré-tratamento de biomassa para preparar bioetanol
BRPI1015444A2 (pt) método para produzir (+)-zizaeno
BRPI1014579A2 (pt) método de transferência de polipeptídeo para células
BRPI1008253A2 (pt) Metoso para tratar biomassa
DK2685554T3 (da) Siliciumdioxid-solcelle
BRPI1011394A8 (pt) método para avaliação de responsividade de linforma de células b ao tratamento com anticorpos anti-cd40
BR112012027715A2 (pt) método e célula fotovoltaica
ES2453203B1 (es) Concentrador solar
BR112013016341A2 (pt) método de congelamento de células
FI20095645A (fi) Ohut paristo
DE112010003235A5 (de) Solarkonzentrator
BR112012022525A2 (pt) método para produzir butanol
DE112011101133T8 (de) Brennstoffzelle
BRPI1010684A2 (pt) método para determinar o potencial cardiorregenerativo de células mamíferas
IT1395180B1 (it) Apparato per trasferire oggetti
BR112012002051A2 (pt) método para classificar chapas elétricas
BRPI1014093A2 (pt) método para evitar perda de líquido, e, coletor de fração
AT508315A3 (de) Solaranlage
IT1395181B1 (it) Apparato per trasferire oggetti

Legal Events

Date Code Title Description
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL